Latest news, press releases, and SEC filings for Caris Life Sciences Inc (CAI) https://caymanjournal.com/stock/CAI en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 21:38:28 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is a **DEF 14A, or Proxy Statement**, for Caris Life Sciences. You can think of it as a detailed invitation and information packet for the company's upcoming annual shareholder meeting. Its main job is to give shareholders the info they need to vote on important compa https://caymanjournal.com/stock/CAI/sec-filing/0002019410-26-000032 https://caymanjournal.com/stock/CAI/sec-filing/0002019410-26-000032 Thu, 23 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is Caris Life Sciences' **Annual Report to Shareholders (ARS)**. Think of it as the company's comprehensive "year in review" document, sent directly to investors. It combines the formal 10-K financial report with a more visual, strategic overview of the business. You https://caymanjournal.com/stock/CAI/sec-filing/0002019410-26-000034 https://caymanjournal.com/stock/CAI/sec-filing/0002019410-26-000034 Thu, 23 Apr 2026 00:00:00 GMT SEC Filing